Table 2.

Analysis of serum microribonucleic acid‐192 and clinical parameters

Parameters	r	P	Adjusted age and sex
			r	P
Sex†	0.011	0.885	–	–
Age	0.003	0.986	–	–
Smoking†	−0.045	0.556	−0.066	0.386
Drinking†	−0.160*	0.034	−0.064	0.402
Duration	−0.364**	0	−0.407**	0
BMI	−0.118	0.121	−0.118	0.123
WHR	−0.249**	0.001	−0.259**	0.001
HbA1c	−0.390**	0	−0.393**	0
SBP	−0.376**	0	−0.379**	0
TG	−0.155*	0.041	−0.155*	0.041
TC	−0.123	0.105	−0.123	0.108
HDL‐c	0.092	0.228	0.091	0.233
LDL‐c	−0.009	0.909	−0.008	0.917
FINS	−0.404**	0	−0.409**	0
ACR	−0.233**	0.003	−0.234**	0.003
HOMA‐IS	−0.154	0.117	−0.159	0.108
HOMA‐IR	−0.360**	0	−0.362**	0
HOMA‐β	0.264**	0.007	0.261**	0.008
sCr	−0.163*	0.031	−0.173*	0.023
BUN	−0.159*	0.036	−0.161*	0.034
uMA	−0.242**	0.001	−0.243**	0.001

ACR, albumin‐to‐creatinine ratio; BMI, body mass index; BUN, blood urea nitrogen; FINS, fasting insulin; HbA1c, hemoglobin A1c; HDL‐c, high‐density lipoprotein cholesterol; HOMA‐β, homeostatic model assessment of β‐cell function; HOMA‐IR, homeostatic model assessment of insulin resistance; HOMA‐IS, homeostatic model assessment of insulin secretion; LDL‐c, low‐density lipoprotein cholesterol; SBP, systolic blood pressure; sCr, serum creatinine; TC, total cholesterol; TG, triglyceride; uMA, urinary microalbumin; WHR, waist‐to‐hip ratio. ^†Spearman's correlation analysis, others using Pearson's correlation analysis. *P < 0.05, **P < 0.01.